Michael Jay, Ph.D.
Dr. Jay is a Founder of Arcato and serves as Chief Technology Officer. Dr. Jay is the Fred Eshelman Chair and distinguished professor of molecular pharmaceutics at the University of North Carolina at Chapel Hill, and is an expert on drug delivery and formulations. Dr. Jay joined the UNC Eshelman School of Pharmacy in 2008 after a 27 year career at the University of Kentucky College of Pharmacy. (more…)
Yong Zhang, Ph.D.
Dr. Zhang serves as Chief Scientific Officer of Arcato. He is the co-author of over 20 peer-reviewed publications in academic journals and conferences. He is named on several patents in the drug development space, and has been an invited speaker for many pharmaceutical companies and universities. Before his time with Arcato, Dr. Zhang worked in various academic and industrial positions, including 5 years at GlaxoSmithKline, AstraZeneca, and a clinical-stage biotechnology company listed on NASDAQ. He has extensive regulatory filing and licensing experience in the pharmaceutical industry. He is also an executive team member of the Chinese Association of Science and Technology, and a board member of its North Carolina Chapter. Dr. Zhang obtained Ph.D. in Pharmaceutical Sciences from UNC Eshelman School of Pharmacy.
Christopher S. Meldrum
Mr. Meldrum serves as Director of Arcato. Mr. Meldrum is a serial entrepreneur, having launched multiple successful start-up companies in the biotechnology and medical devices sectors from university-based technology. In addition to his work with Arcato, Mr. Meldrum serves as a Managing Director of Golden Pine Ventures, LLC. (more…)
Robert M. Jordan
Mr. Jordan serves as Chief Commercial Officer for Arcato. Over his career, Mr. Jordan has run a variety of companies, obtaining a strong knowledge of manufacturing, services and publishing. He has a history as an innovative leader developing numerous high performance teams. In addition, Mr. Jordan has orchestrated the successful turnaround of eight companies, improving shareholder value while retaining several hundred jobs in his 25 years of professional endeavors. (more…)
Mr. Scott serves as Oral Health Product Marketing Advisor for Arcato. Mr. Scott is currently a Partner with HealthQuest Capital, a Sofinnova fund which he helped launch in 2013. Randy’s industry successes include starting NovaMin Technology, Inc., and leading it through financing, growth and eventual acquisition by GlaxoSmithKline (at a 10x return on capital); (more…)
G. Thomas Kleumper, DMD, MS
Dr. Kleumper services as orthodontic affairs advisor for Arcato. Dr. Kleumper works as Chief and Program Director of the Division of Orthodontics at the University of Kentucky, and is co-inventor of the patented technology behind the OraWax™ product. Dr. Kleumper has received a number of awards and accolades for his work in orthodontics research. Dr. Kleumper’s clinical practice inspired him to seek a solution for his patients’ oral brace discomfort, leading eventually to a partnership with Dr. Jay and the patented OraWax™ technology.